Carlsmed® uses patient data and digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient, giving you the power to achieve your surgical plan. Carlsmed leverages AI and predictive analytics to utilize prior outcomes data for personalizing the treatment of complex spinal deformities. Its mission is to improve outcomes and decrease the cost of healthcare for complex spine surgery and beyond. The company’s proprietary Aprevo platform makes surgical plans and devices tailored to the precise medical situation of every individual patient. This is transforming healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles.

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery . The company’s aprevo® devices are designed to improve the standard of care for surgical treatment of patients with adult spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient. The Carlsmed® aprevo® devices are FDA cleared and have been granted FDA Breakthrough Designation, an industry first for any implanted device, and are commercially available in the U.S.